APA

Bellino R., Cortese P., Danese S., De Sanctis C., Durando A., Genta F., Grio R., Giardina G., Katsaros D., Massobrio M., Richiardi G. & Vicelli R. (20010222). Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients. : Anticancer research.

Chicago

Bellino R, Cortese P, Danese S, De Sanctis C, Durando A, Genta F, Grio R, Giardina G, Katsaros D, Massobrio M, Richiardi G and Vicelli R. 20010222. Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients. : Anticancer research.

Harvard

Bellino R., Cortese P., Danese S., De Sanctis C., Durando A., Genta F., Grio R., Giardina G., Katsaros D., Massobrio M., Richiardi G. and Vicelli R. (20010222). Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients. : Anticancer research.

MLA

Bellino R, Cortese P, Danese S, De Sanctis C, Durando A, Genta F, Grio R, Giardina G, Katsaros D, Massobrio M, Richiardi G and Vicelli R. Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients. : Anticancer research. 20010222.